| Released | Contributor | Author | Title | Pages | Price |
| 26-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for COSMETICS | 18 |
$49 |
| 26-Nov-2009 | New Constructs, LLC |
N/A
| REV: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 25-Nov-2009 | Zacks Investment Research Inc. |
N/A
| REVLON INC-A (REV) Zacks Company Snapshot | 1 |
$10 |
| 24-Nov-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of REVLON INC -CL A including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Soap & Cosmetics Intelligence Monitor: overall outlook VERY STRONG - 7 new Leaders; one new Laggard. | 23 |
$20 |
| 23-Nov-2009 | Zacks Investment Research Inc. |
N/A
| REVLON INC-A (REV) Zacks Company Snapshot | 1 |
$10 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| Revlon Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for REV | 13 |
$25 |
| 23-Nov-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 |
| 22-Nov-2009 | Wright Reports |
N/A
| Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) | 103 |
$169 |
1.48% Nasdaq 
Research Reports
